Back
Universal Vs. NovoCure Industry Stock Comparison
Sell
20
UVV
Universal
Last Price:
$50.76
Seasonality Move:
3.45%
Sell
47
NVCR
NovoCure
Last Price:
$27.01
Seasonality Move:
5.69%
Sell
47
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
UVV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.18 | Sell |
Relative Strength Index (14 RSI): | 37.73 | Sell |
Chaikin Money Flow: | 103197 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.91 - 55.23) | Sell |
Bollinger Bands (100): | (50.88 - 55.34) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 46.86 | Sell |
Chaikin Money Flow: | 104159 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.15 - 31.15) | Sell |
Bollinger Bands (100): | (15.12 - 27.36) | Buy |
UVV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.59 | Buy |
20-day SMA: | 52.45 | Sell |
50-day SMA: | 54.38 | Sell |
200-day SMA: | 51.74 | Sell |
8-day EMA: | 51 | Sell |
20-day EMA: | 52.15 | Sell |
50-day EMA: | 53.18 | Sell |
200-day EMA: | 52.58 | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.62 | Buy |
20-day SMA: | 28.61 | Sell |
50-day SMA: | 25.8 | Buy |
200-day SMA: | 19.68 | Buy |
8-day EMA: | 27.03 | Sell |
20-day EMA: | 27.72 | Sell |
50-day EMA: | 25.96 | Buy |
200-day EMA: | 21.9 | Buy |
Universal Earnings Growth & UVV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.03 per share.
Universal Technical Analysis
Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |